CSIMarket Company Name, Ticker, Customers, else..
 
Mersana Therapeutics inc   (NASDAQ: MRSN)
 

MRSN's Market share relative to its competitors, as of Q3 2025

As of Q3 2025 (Revenue in Millions of $)

Date modified: 2026-08-29T06:32:56+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months
Q3 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE
A Quarter Before
Q2 2025
Mersana Therapeutics inc 33.18 0.78% 0.87 % 0.27 %
Madrigal Pharmaceuticals Inc 1,132.49 26.65% 28.86% 27.86%
Supernus Pharmaceuticals inc 776.83 18.28% 17.36% 18.59%
Hutchmed china Limited 548.51 12.91% 12.91% 0.00%
Iovance Biotherapeutics inc 285.61 6.72% 7.87% 6.39%
Verona Pharma Plc 221.67 5.22% 8.17% 6.82%
56 more competitors available

Sign in to see all competitors for Mersana Therapeutics inc .

Sign In Create Free Account



MRSN's Market share relative to its competitors, as of Q3 2025 within the Major Pharmaceutical Preparations Industry
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months Ending
Q2 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE

Q2 2025
Mersana Therapeutics inc 0.84% 0.97% 0.95 % 0.29 %
Madrigal Pharmaceuticals Inc 28.58% 26.76% 31.33% 29.77%
Supernus Pharmaceuticals inc 19.60% 20.07% 18.84% 19.86%
Hutchmed china Limited 13.84% 17.59% 13.84% 17.59%
Verona Pharma Plc 5.59% 0.00% 8.87% 7.29%
Rhythm Pharmaceuticals Inc 5.48% 5.30% 6.13% 5.75%
55 more companies available

Sign in to see all industry competitors for Mersana Therapeutics inc .

Sign In Create Free Account



MRSN's Market share relative to its competitors, as of Q3 2025 within the Healthcare Sector
As of Q3 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
12 Months Ending
Q2 2025		 MARKET SHARE
MRQ
Q3 2025		 MARKET SHARE

Q2 2025
Mersana Therapeutics inc 0.78% 0.90% 0.87 % 0.27 %
Madrigal Pharmaceuticals Inc 26.65% 24.92% 28.86% 27.86%
Supernus Pharmaceuticals inc 18.28% 18.70% 17.36% 18.59%
Hutchmed china Limited 12.91% 16.39% 12.91% 16.39%
Iovance Biotherapeutics inc 6.72% 6.85% 7.87% 6.39%
Verona Pharma Plc 5.22% 0.00% 8.17% 6.82%
56 more companies available

Sign in to see all sector competitors for Mersana Therapeutics inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Mersana Therapeutics inc's market divisions, geographic dispersion, segments, products, and services, visit Mersana Therapeutics inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.